article thumbnail

Pharma Horizons: Artificial Intelligence

European Pharmaceutical Review

The first in our inaugural Pharma Horizons report series is dedicated to exploring the latest advances in artificial intelligence (AI) and machine learning (ML) for drug development, pharmaceutical manufacturing and quality control. Additionally the pharmaceutical AI market is projected to reach $11.8

Pharma 127
article thumbnail

Pharma Horizons: Environmental Monitoring

European Pharmaceutical Review

Download this report to discover key environmental monitoring trends impacting pharmaceutical manufacturers today, including the latest requirements for contamination control, the shift towards rapid methods and the latest regulations on bacterial endotoxin testing. Interested? Register your details now to download for free today!

Pharma 69
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

PhRMA lies to protect pharma profits

World of DTC Marketing

pharmaceutical companies booked tens of billions of dollars in revenue: Johnson & Johnson ($94 billion), Pfizer ($81 billion), AbbVie ($56 billion), Merck & Co. ($49 Pharmaceutical companies often claim that the research costs of unsuccessful drugs also have to be considered. In 2021 alone, the top U.S.

Pharma 255
article thumbnail

Is the pharmaceutical sector realising its potential for sustainable manufacturing?

European Pharmaceutical Review

The pharmaceutical industry is becoming increasingly conscious of emissions and the importance of sustainable manufacturing. Globally, the pharmaceutical sector emitted around 52 megatonnes of CO 2 in 2015, the most recent period for which detailed numbers are available. appeared first on European Pharmaceutical Review.

article thumbnail

Pharma unite to secure renewable energy in key manufacturing markets

European Pharmaceutical Review

This step is important as these countries are key markets for pharmaceuticals manufacturing. GSK propels its progress to Net Zero Renewable energy in the pharma supply chain The SMI Health Systems Task Force is a public-private partnership launched at COP26. These targets could address 3.5

article thumbnail

Dr. Reddy's scolded for maintenance shortfalls in new FDA Form 483 filing

Fierce Pharma

It’s critical to keep your workplace equipment clean and calibrated—especially in the realm of pharmaceutical manufacturing. Now, Dr. | It’s critical to keep your workplace equipment clean and calibrated—especially in the realm of pharmaceutical manufacturing.

article thumbnail

Facilities of the Future: Meeting the Demands of Breakthrough Therapeutics

PharmaTech

As breakthrough therapeutics in the pharma pipeline approach commercialization, pharmaceutical manufacturing facilities must evolve to meet demand.